| Ipsen Pharma Schweiz GmbH - Somatuline Autogel 120 mg, Injektionslösung |
| 56148 | | 03 | | Somatuline Autogel 120 mg | | Injektionslösung | | H01CB03 | | Lanreotide | | 15.07.2004 | | |
|
| Composition |
| lanreotidum 120 mg ut lanreotidi acetas, aqua ad iniectabile q.s. ad solutionem pro 488 mg, pro vitro. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Lanreotide | 120 mg |
| | BAG: Active Agent | Dose |
|---|
| Lanreotide | 120 mg |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | | 1290.70 | 1420.15 | A | SL | Yes |
|
